Neurocrine Clinical Site

Bloomfield Hills, Michigan 48371

0 studies enrolling now · 3 studies all time

What they study most

Tardive Dyskinesia (TD), Tourette Syndrome

Studies at this site

• Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome — Stopped early
• Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome — Completed
• Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia — Completed